Abu Sheikha Drugstore expands its medical logistics services with first bioabsorbable coronary stent
- Jordan: Saturday, September 08 - 2012 at 16:46
- PRESS RELEASE
Abu Sheikha Drugstore has completed procedures for registering the world's first bioabsorbable vascular stent under the trade mark, ABSORB, in Jordan Food and Drug Administration (JFDA).
The device recently approved by CE Mark heralds a new era in angioplasty given its capability in restoring blood flow by opening a clogged vessel and providing support to the coronary artery until the device dissolves shortly after being implanted, leaving behind a treated vessel free of a permanent metallic implant. In addition, the need to administer long-term dual anti-platelet therapy to patients may be reduced because the temporary scaffold is completely absorbed.
In his comment, Taiseer Abu Sheikha, the General Manager of Abu Sheikha Drugstore, said, "We at Abu Sheikha Drugstore pay special keenness to supplying the medical sector in the Kingdom with the latest advances in the world of medicine to make it a destination of choice for patients seeking advanced healthcare services."
"To ensure the best possible outcome from vascular device implantations, an elite team of Jordanian cardiology physicians will receive training in a number of the European medical centers on the successful deployment of the coronary device," Abu Sheikha added.
Remarkably, ABSORB is made of Polylactide, a proven biocompatible material that is commonly used in medical implants such as absorbable sutures, and has been developed to replace the old bare and drug eluting metal stents used in the treatment of coronary artery diseases.
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of Mediaquest FZ LLC. Mediaquest FZ LLC is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.